)
Visual
test
S2Medical
S2Medical (S2M) investor relations material
S2Medical Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2025 earnings summary22 Aug, 2025
Executive summary
Net sales for the first half of 2025 reached 6.9 MSEK, more than doubling year-over-year, driven by increased sales from the Abena partnership and higher marketing efforts.
Operating costs rose as business normalized and marketing investments increased, impacting personnel and external expenses.
Net profit for the period was 0.2 MSEK, down from 6.9 MSEK last year, mainly due to lower other operating income after a one-time technology sale in 2024.
The company remains debt-free since 2024, providing a strong financial foundation.
Financial highlights
Net sales: 6.9 MSEK (2.9 MSEK in H1 2024), up 138% year-over-year.
Operating result: -0.5 MSEK (7.0 MSEK in H1 2024).
Net profit: 0.2 MSEK (6.9 MSEK in H1 2024).
Earnings per share: 0.00 SEK (0.03 SEK in H1 2024).
Cash flow for the period: 0.3 MSEK (0.0 MSEK in H1 2024).
Cash and cash equivalents at period end: 1.3 MSEK.
Equity ratio: 73%.
Outlook and guidance
Focus remains on growing base sales with healthy margins and introducing products with faster revenue potential.
Long-term value expected from innovative wound healing and infection control technologies, especially Admercin.
Strategic partnerships and selective divestments may be pursued to maximize shareholder value.
Admercin: Next key development milestones?
Quantify expected revenue from Protech deal
How will negative operating cash flow impact liquidity?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- 6 FebSCW
Record backlog and 89% y/y revenue growth highlight strong momentum in space projects. - 6 FebNVDA
AI-driven virtual twins and accelerated computing are revolutionizing design and manufacturing. - 6 FebSPKSJF
Record income, strong growth, and robust capital position despite lower interest income. - 6 FebISCTR
Net profit hit TL 67.4 billion in 2025, with strong NIM, fee growth, and solid 2026 outlook. - 6 FebSCW73% revenue growth and record backlog driven by new space contracts and strategic investments.
- 6 FebCDP
2025 FFO/share rose 5.8% with strong leasing and retention; 2026 guidance signals further growth. - 6 FebSCWRevenue at 15.86 mln PLN, backlog 17.14 mln PLN, and major space contracts drive 2025 outlook.
- 6 FebPENG
All proposals passed, with no questions raised during the Q&A session. - 6 FebSCWQ2 2024 revenue up 115% y/y, backlog nearly doubled, Space segment leads growth.
- 6 FebPECO
2026 FFO per share growth guided at 5.5% with record occupancy and strong acquisitions.
Next S2Medical earnings date
Q4 202520 Feb, 2026
S2Medical
Next S2Medical earnings date
Q4 202520 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
S2Medical AB is a Swedish medical technology company specializing in wound care solutions, particularly for burns and chronic wounds. The company develops, produces, and markets a range of innovative products that cover the entire wound healing process. Their portfolio includes INSTAQRETT, a sterile single-use mechanical debridement tool, and the Epiprotect line, which features synthetic substitutes for allografts and xenografts, ulcer dressings, and blood-stilling membranes. Additionally, they distribute Silverlon antimicrobial dressings in the Nordic countries and operate the S2Clinic, a wound healing center in Sweden. The company is headquartered in Linköping, Sweden, and its shares are listed on the Nasdaq Stockholm.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage